-
2
-
-
0017204772
-
Clinical use of buprenorphine in chronic administration
-
Adriaensen H., Van De Walle J. Clinical use of buprenorphine in chronic administration. Acta Anaesthesiol. Belg. 1976, 27:187-191.
-
(1976)
Acta Anaesthesiol. Belg.
, vol.27
, pp. 187-191
-
-
Adriaensen, H.1
Van De Walle, J.2
-
3
-
-
0021184489
-
The metabolism and excretion of buprenorphine in humans
-
Cone E.J., Gorodetzky C.W., Yousefnejad D., Buchwald W.F., Johnson R.E. The metabolism and excretion of buprenorphine in humans. Drug Metab. Dispos. 1984, 12:577-581.
-
(1984)
Drug Metab. Dispos.
, vol.12
, pp. 577-581
-
-
Cone, E.J.1
Gorodetzky, C.W.2
Yousefnejad, D.3
Buchwald, W.F.4
Johnson, R.E.5
-
4
-
-
0018147760
-
Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
-
Jasinski D.R., Pevnick J.S., Griffith J.D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch. Gen. Psychiatry 1978, 35:501-516.
-
(1978)
Arch. Gen. Psychiatry
, vol.35
, pp. 501-516
-
-
Jasinski, D.R.1
Pevnick, J.S.2
Griffith, J.D.3
-
5
-
-
0028318472
-
Clinical pharmacology of buprenorphine: ceiling effects at high doses
-
Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., Bigelow G.E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 1994, 55:569-580.
-
(1994)
Clin. Pharmacol. Ther.
, vol.55
, pp. 569-580
-
-
Walsh, S.L.1
Preston, K.L.2
Stitzer, M.L.3
Cone, E.J.4
Bigelow, G.E.5
-
6
-
-
0042360208
-
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
-
Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N. Engl. J. Med. 2003, 349:949-958.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 949-958
-
-
Fudala, P.J.1
Bridge, T.P.2
Herbert, S.3
Williford, W.O.4
Chiang, C.N.5
Jones, K.6
-
7
-
-
0034704453
-
Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine
-
Harris D.S., Jones R.T., Welm S., Upton R.A., Lin E., Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend. 2000, 61:85-94.
-
(2000)
Drug Alcohol Depend.
, vol.61
, pp. 85-94
-
-
Harris, D.S.1
Jones, R.T.2
Welm, S.3
Upton, R.A.4
Lin, E.5
Mendelson, J.6
-
8
-
-
0037987960
-
Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?
-
Mendelson J., Jones R.T. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?. Drug Alcohol Depend. 2003, 70:S29-S37.
-
(2003)
Drug Alcohol Depend.
, vol.70
-
-
Mendelson, J.1
Jones, R.T.2
-
9
-
-
77955940327
-
Buprenorphine in the treatment of opiate dependence
-
Wesson D.R., Smith D.E. Buprenorphine in the treatment of opiate dependence. J. Psychoactive Drugs 2010, 42:161-175.
-
(2010)
J. Psychoactive Drugs
, vol.42
, pp. 161-175
-
-
Wesson, D.R.1
Smith, D.E.2
-
10
-
-
79954558512
-
Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review
-
Yokell M.A., Zaller N.D., Green T.C., Rich J.D. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr. Drug Abuse Rev. 2011, 4:28-41.
-
(2011)
Curr. Drug Abuse Rev.
, vol.4
, pp. 28-41
-
-
Yokell, M.A.1
Zaller, N.D.2
Green, T.C.3
Rich, J.D.4
-
11
-
-
0035885323
-
Deaths involving buprenorphine: a compendium of French cases
-
Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 2001, 121:65-69.
-
(2001)
Forensic Sci. Int.
, vol.121
, pp. 65-69
-
-
Kintz, P.1
-
12
-
-
84857042995
-
Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning
-
Häkkinen M., Launiainen T., Vuori E., Ojanperä I. Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur. J. Clin. Pharmacol. 2012, 68:301-309.
-
(2012)
Eur. J. Clin. Pharmacol.
, vol.68
, pp. 301-309
-
-
Häkkinen, M.1
Launiainen, T.2
Vuori, E.3
Ojanperä, I.4
-
13
-
-
84862683744
-
Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome
-
Seldén T., Ahlner J., Druid H., Kronstrand R. Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome. Forensic Sci. Int. 2012, 220:284-290.
-
(2012)
Forensic Sci. Int.
, vol.220
, pp. 284-290
-
-
Seldén, T.1
Ahlner, J.2
Druid, H.3
Kronstrand, R.4
-
14
-
-
0027203690
-
The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand
-
Robinson G.M., Dukes P.D., Robinson B.J., Cooke R.R., Mahoney G.N. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend. 1993, 33:81-86.
-
(1993)
Drug Alcohol Depend.
, vol.33
, pp. 81-86
-
-
Robinson, G.M.1
Dukes, P.D.2
Robinson, B.J.3
Cooke, R.R.4
Mahoney, G.N.5
-
15
-
-
0034033451
-
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
-
Strain E.C., Stoller K., Walsh S.L., Bigelow G.E. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berl.) 2000, 148:374.
-
(2000)
Psychopharmacology (Berl.)
, vol.148
, pp. 374
-
-
Strain, E.C.1
Stoller, K.2
Walsh, S.L.3
Bigelow, G.E.4
-
16
-
-
33947127824
-
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users
-
Alho H., Sinclair D., Vuori E., Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend. 2007, 88:75-78.
-
(2007)
Drug Alcohol Depend.
, vol.88
, pp. 75-78
-
-
Alho, H.1
Sinclair, D.2
Vuori, E.3
Holopainen, A.4
-
17
-
-
65549137670
-
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
-
Bruce R.D., Govindasamy S., Sylla L., Kamarulzaman A., Altice F.L. Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market. Am. J. Drug Alcohol Abuse 2009, 35:68-72.
-
(2009)
Am. J. Drug Alcohol Abuse
, vol.35
, pp. 68-72
-
-
Bruce, R.D.1
Govindasamy, S.2
Sylla, L.3
Kamarulzaman, A.4
Altice, F.L.5
-
18
-
-
77949411784
-
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers
-
Comer S.D., Sullivan M.A., Vosburg S.K., Manubay J., Amass L., Cooper Z.D., et al. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction 2010, 105:709-718.
-
(2010)
Addiction
, vol.105
, pp. 709-718
-
-
Comer, S.D.1
Sullivan, M.A.2
Vosburg, S.K.3
Manubay, J.4
Amass, L.5
Cooper, Z.D.6
-
19
-
-
77955466653
-
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers
-
Duke A.N., Correia C.J., Walsh S.L., Bigelow G.E., Strain E.C. Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology (Berl.) 2010, 211:303-312.
-
(2010)
Psychopharmacology (Berl.)
, vol.211
, pp. 303-312
-
-
Duke, A.N.1
Correia, C.J.2
Walsh, S.L.3
Bigelow, G.E.4
Strain, E.C.5
-
20
-
-
79954515756
-
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users
-
Bazazi A.R., Yokell M., Fu J.J., Rich J.D., Zaller N.D. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J. Addict. Med. 2011, 5:175-180.
-
(2011)
J. Addict. Med.
, vol.5
, pp. 175-180
-
-
Bazazi, A.R.1
Yokell, M.2
Fu, J.J.3
Rich, J.D.4
Zaller, N.D.5
-
21
-
-
80053571601
-
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing
-
Larance B., Degenhardt L., Lintzeris N., Bell J., Winstock A., Dietze P., et al. Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. Drug Alcohol Depend. 2011, 118:265-273.
-
(2011)
Drug Alcohol Depend.
, vol.118
, pp. 265-273
-
-
Larance, B.1
Degenhardt, L.2
Lintzeris, N.3
Bell, J.4
Winstock, A.5
Dietze, P.6
-
22
-
-
84155164697
-
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians
-
Johanson C., Arfken C.L., di Menza S., Schuster C.R. Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Drug Alcohol Depend. 2012, 120:190-195.
-
(2012)
Drug Alcohol Depend.
, vol.120
, pp. 190-195
-
-
Johanson, C.1
Arfken, C.L.2
di Menza, S.3
Schuster, C.R.4
-
23
-
-
84896404240
-
Urine naloxone concentration at different phases of buprenorphine maintenance treatment
-
(Epub ahead of print)
-
Heikman P., Häkkinen M., Gergov M., Ojanperä I. Urine naloxone concentration at different phases of buprenorphine maintenance treatment. Drug Test. Anal. 2013, (Epub ahead of print). 10.1002/dta.1464.
-
(2013)
Drug Test. Anal.
-
-
Heikman, P.1
Häkkinen, M.2
Gergov, M.3
Ojanperä, I.4
-
24
-
-
69949101444
-
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved
-
Degenhardt L., Randall D., Hall W., Law M., Butler T., Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009, 105:9-15.
-
(2009)
Drug Alcohol Depend.
, vol.105
, pp. 9-15
-
-
Degenhardt, L.1
Randall, D.2
Hall, W.3
Law, M.4
Butler, T.5
Burns, L.6
-
25
-
-
56449112183
-
Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine
-
Kronstrand R., Nyström I., Andersson M., Gunnarsson L., Hägg S., Josefsson M., et al. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine. J. Anal. Toxicol. 2008, 32:586-593.
-
(2008)
J. Anal. Toxicol.
, vol.32
, pp. 586-593
-
-
Kronstrand, R.1
Nyström, I.2
Andersson, M.3
Gunnarsson, L.4
Hägg, S.5
Josefsson, M.6
-
26
-
-
0031968220
-
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine
-
Kuhlman J.J., Levine B., Johnson R.E., Fudala P.J., Cone E.J. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction 1998, 93:549-559.
-
(1998)
Addiction
, vol.93
, pp. 549-559
-
-
Kuhlman, J.J.1
Levine, B.2
Johnson, R.E.3
Fudala, P.J.4
Cone, E.J.5
-
27
-
-
2042470124
-
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone
-
Harris D.S., Mendelson J.E., Lin E.T., Upton R.A., Jones R.T. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone. Clin. Pharmacokinet. 2004, 43:329-340.
-
(2004)
Clin. Pharmacokinet.
, vol.43
, pp. 329-340
-
-
Harris, D.S.1
Mendelson, J.E.2
Lin, E.T.3
Upton, R.A.4
Jones, R.T.5
-
28
-
-
22244462451
-
Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence
-
Elkader A., Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin. Pharmacokinet. 2005, 44:661-680.
-
(2005)
Clin. Pharmacokinet.
, vol.44
, pp. 661-680
-
-
Elkader, A.1
Sproule, B.2
-
29
-
-
58149109889
-
Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers
-
Dowling J., Isbister G.K., Kirkpatrick C.M., Naidoo D., Graudins A. Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers. Ther. Drug Monit. 2008, 30:490-496.
-
(2008)
Ther. Drug Monit.
, vol.30
, pp. 490-496
-
-
Dowling, J.1
Isbister, G.K.2
Kirkpatrick, C.M.3
Naidoo, D.4
Graudins, A.5
-
30
-
-
84860391245
-
Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women
-
Concheiro M., Jones H.E., Johnson R.E., Choo R., Huestis M.A. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther. Drug Monit. 2011, 33:619-626.
-
(2011)
Ther. Drug Monit.
, vol.33
, pp. 619-626
-
-
Concheiro, M.1
Jones, H.E.2
Johnson, R.E.3
Choo, R.4
Huestis, M.A.5
-
31
-
-
79959965800
-
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
-
Middleton L.S., Nuzzo P.A., Lofwall M.R., Moody D.E., Walsh S.L. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Addiction 2011, 106:1460-1473.
-
(2011)
Addiction
, vol.106
, pp. 1460-1473
-
-
Middleton, L.S.1
Nuzzo, P.A.2
Lofwall, M.R.3
Moody, D.E.4
Walsh, S.L.5
-
32
-
-
80053570710
-
Gender differences in pharmacokinetics of maintenance dosed buprenorphine
-
Moody D.E., Fang W.B., Morrison J., McCance-Katz E. Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug Alcohol Depend. 2011, 118:479-483.
-
(2011)
Drug Alcohol Depend.
, vol.118
, pp. 479-483
-
-
Moody, D.E.1
Fang, W.B.2
Morrison, J.3
McCance-Katz, E.4
-
33
-
-
0015758661
-
Disposition of naloxone-7,8,3H in normal and narcotic-dependent men
-
Fishman J., Roffwarg H., Hellman L. Disposition of naloxone-7,8,3H in normal and narcotic-dependent men. J. Pharmacol. Exp. Ther. 1973, 187:575-580.
-
(1973)
J. Pharmacol. Exp. Ther.
, vol.187
, pp. 575-580
-
-
Fishman, J.1
Roffwarg, H.2
Hellman, L.3
-
34
-
-
70349873940
-
Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry
-
Fang W.B., Chang Y., McCance-Katz E.F., Moody D.E. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 2009, 33:409-417.
-
(2009)
J. Anal. Toxicol.
, vol.33
, pp. 409-417
-
-
Fang, W.B.1
Chang, Y.2
McCance-Katz, E.F.3
Moody, D.E.4
-
36
-
-
84862621692
-
Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry
-
McMillin G.A., Davis R., Carlisle H., Clark C., Marin S.J., Moody D.E. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2012, 36:81-87.
-
(2012)
J. Anal. Toxicol.
, vol.36
, pp. 81-87
-
-
McMillin, G.A.1
Davis, R.2
Carlisle, H.3
Clark, C.4
Marin, S.J.5
Moody, D.E.6
-
37
-
-
0031655824
-
Six deaths linked to concomitant use of buprenorphine and benzodiazepines
-
Reynaud M., Petit G., Potard D., Courty P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 1998, 93:1385-1392.
-
(1998)
Addiction
, vol.93
, pp. 1385-1392
-
-
Reynaud, M.1
Petit, G.2
Potard, D.3
Courty, P.4
-
38
-
-
33748553325
-
A survey of buprenorphine related deaths in Singapore
-
Lai S.H., Yao Y.J., Lo D.S.T. A survey of buprenorphine related deaths in Singapore. Forensic Sci. Int. 2006, 162:80-86.
-
(2006)
Forensic Sci. Int.
, vol.162
, pp. 80-86
-
-
Lai, S.H.1
Yao, Y.J.2
Lo, D.S.T.3
-
39
-
-
79952073483
-
Fatal poisoning due to snorting buprenorphine and alcohol consumption
-
Ferrant O., Papin F., Clin B., Lacroix C., Saussereau E., Remoué J., et al. Fatal poisoning due to snorting buprenorphine and alcohol consumption. Forensic Sci. Int. 2011, 204:e8-e11.
-
(2011)
Forensic Sci. Int.
, vol.204
-
-
Ferrant, O.1
Papin, F.2
Clin, B.3
Lacroix, C.4
Saussereau, E.5
Remoué, J.6
-
40
-
-
84865005087
-
Polydrug abuse: a review of opioid and benzodiazepine combination use
-
Jones J.D., Mogali S., Comer S.D. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012, 125:8-18.
-
(2012)
Drug Alcohol Depend.
, vol.125
, pp. 8-18
-
-
Jones, J.D.1
Mogali, S.2
Comer, S.D.3
-
41
-
-
84870253649
-
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
-
Alhaddad H., Cisternino S., Declèves X., Tournier N., Schlatter J., Chiadmi F., et al. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice. Crit. Care Med. 2012, 40:3215-3223.
-
(2012)
Crit. Care Med.
, vol.40
, pp. 3215-3223
-
-
Alhaddad, H.1
Cisternino, S.2
Declèves, X.3
Tournier, N.4
Schlatter, J.5
Chiadmi, F.6
-
42
-
-
79953032006
-
Fatal poisoning in drug addicts in the Nordic countries in 2007
-
Simonsen K.W., Normann P.T., Ceder G., Vuori E., Thordardottir S., Thelander G., et al. Fatal poisoning in drug addicts in the Nordic countries in 2007. Forensic Sci. Int. 2011, 207:170-176.
-
(2011)
Forensic Sci. Int.
, vol.207
, pp. 170-176
-
-
Simonsen, K.W.1
Normann, P.T.2
Ceder, G.3
Vuori, E.4
Thordardottir, S.5
Thelander, G.6
-
43
-
-
84865656784
-
Comparison of fatal poisonings by prescription opioids
-
Häkkinen M., Launiainen T., Vuori E., Ojanperä I. Comparison of fatal poisonings by prescription opioids. Forensic Sci. Int. 2012, 222:327-331.
-
(2012)
Forensic Sci. Int.
, vol.222
, pp. 327-331
-
-
Häkkinen, M.1
Launiainen, T.2
Vuori, E.3
Ojanperä, I.4
-
44
-
-
84870922935
-
Twelve-year trend in treatment seeking for buprenorphine abuse in Finland
-
Uosukainen H., Kauhanen J., Voutilainen S., Föhr J., Paasolainen M., Tiihonen J., et al. Twelve-year trend in treatment seeking for buprenorphine abuse in Finland. Drug Alcohol Depend. 2013, 127:207-214.
-
(2013)
Drug Alcohol Depend.
, vol.127
, pp. 207-214
-
-
Uosukainen, H.1
Kauhanen, J.2
Voutilainen, S.3
Föhr, J.4
Paasolainen, M.5
Tiihonen, J.6
-
45
-
-
47749151132
-
A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone)
-
Simojoki K., Vorma H., Alho H. A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone). Subst. Abuse Treat. Prev. Policy 2008, 3:16.
-
(2008)
Subst. Abuse Treat. Prev. Policy
, vol.3
, pp. 16
-
-
Simojoki, K.1
Vorma, H.2
Alho, H.3
|